6-Chloropurinum Ribonucleoside CAS 2004-06-0 Puritas ≥99.0% (HPLC) Factory
Manufacturer Supple, Puritas, Commercial Productio
Nomen chemicum: 6-Chloropurinum Ribonucleoside
CAS: 2004-06-0
Nomen chemicum | 6-Chloropurinum Ribonucleoside |
Synonyma | 6-CLPR;6-Chloropurine Riboside;6-Chloropurine-9-Riboside |
CAS Number | 2004-06-0 |
CATTUS Number | RF-PI506 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C10H11ClN4O4 |
M. Pondus | 286.67 |
Liquescens punctum | 158.0 ad 162.0℃ (decl.) |
Solubilitas | Solutum in Methanol |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Lux Yellow Crystallina pulveris |
Puritas / Analysis Methodus | ≥99.0% (HPLC) |
Damnum in Siccatio | ≤0.50% |
Residere in Ignition | ≤0.10% |
Metalla gravis | ≤10ppm |
una immunditia | ≤0.50% |
Totalis immunditias | ≤1.0% |
Repono | Condite in loco frigido et sicco, 2-8℃ |
Test Standard | Enterprise Standard |
Consuetudinem | Pharmaceutical intermedia |
Res of Analysis
Description: Lumen Yellow Crystalline pulveris (View by Eye)
Damnum in remittit: NMT 0.50% w/w (100℃ 4h)
Residere in Ignitione: NMT 0.10% (secundum Residuum in Ignitione, CP2005 Excursus 8 N).
Metalla gravia: NMT 10ppm (iuxta Methodum Metallorum gravium, CP2005 Excursus 8 H).
Puritas chromatographica (HPLC): NLT 99.0%
Instrument: SPD-10Avp Column: VP-ODS 250L*4.6
Mobile Phase: CH3CN:H2O=1:9
Fluunt Rate: 1.0mL/min Necem: 254nm
De modo: circa 0.02 g ad 100-mL lagena volumetrica, solve ac dilue cum mobili periodo ad volumen, et ad solutionem experimentalis misce.Tum de 20μL solutionis experimenti injiciunt.Recipis cacumen maioris iuxta aream ordinationem chromatogrammata memorare et ad cacumina responsoria pro cacumine maioris computare.
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
6-Chloropurina Ribonucleoside (CAS: 2004-06-0) media in synthesi organica adhibetur, synthesis intermediorum pharmaceuticae et pharmaceuticae Ingredientis activae (API).